What is the pathophysiology of tetanus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Tetanus

Tetanus results from tetanospasmin, a potent neurotoxin produced by Clostridium tetani, which binds irreversibly to neural tissue and blocks the release of inhibitory neurotransmitters, causing uncontrolled muscle spasms and rigidity. 1

Causative Organism and Entry

  • Clostridium tetani is a ubiquitous, spore-forming, motile Gram-positive anaerobic bacillus found in high concentrations in soil and animal excrement 1
  • The spores enter the body through breaches in the skin or mucous membranes 1
  • Germination of spores occurs only under anaerobic conditions, such as in necrotic tissue resulting from deep puncture wounds or blunt trauma 1
  • Direct person-to-person transmission does not occur 1

Toxin Production and Mechanism

  • Once germinated, C. tetani bacilli vegetate and produce tetanospasmin, a powerful exotoxin 1
  • Tetanospasmin binds irreversibly with neural tissue 1
  • The toxin prevents the release of inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in the spinal cord, brainstem motor nuclei, and the brain 2
  • This blockade of inhibitory neurotransmission produces muscle rigidity and tonic spasms of skeletal muscles 1, 2

Clinical Manifestations Based on Pathophysiology

Neuromuscular Effects

  • Trismus (lockjaw) is typically the initial presentation, occurring in 75% of patients 3
  • Dysphagia and laryngeal spasms result from involvement of cranial nerve nuclei 2
  • Rigidity of limbs and paraspinal muscles with opisthotonic posture develops 2
  • Reflex spasms occur in 70% of patients and characterize disease severity 3
  • Frequent severe spasms can be triggered by touch, pain, bright light, or sounds, potentially producing apnea and rhabdomyolysis 2

Autonomic Dysfunction

  • In severe tetanus, autonomic overactivity occurs, causing labile hypertension, tachycardia, increased secretions, sweating, and urinary retention 2
  • Dysautonomia is difficult to manage and represents a common cause of mortality 2

Temporal Progression

  • The incubation period from injury to symptom onset varies from 3 to 21 days (median: 7 days), with extremes of 1 day to several months 1, 4
  • Shorter incubation periods are associated with more severe disease and poorer prognosis 1, 4
  • Longer incubation periods are associated with injuries furthest from the central nervous system 1, 4
  • The disease course is usually intense for ≥4 weeks before subsiding 1, 4

Critical Pathophysiologic Pitfall

The irreversible binding of tetanospasmin to neural tissue is the key pathophysiologic feature that explains why treatment focuses on neutralizing circulating toxin before it binds, rather than reversing already-bound toxin 1, 5. Once the toxin binds to neuronal cell membranes, recovery depends on regeneration of new nerve terminals, which explains the protracted convalescent period and potential for long-term neurologic sequelae 1, 4.

Mortality and Morbidity

  • The case-fatality ratio can be as high as 100% without high-quality medical care, but remains approximately 10-20% even in modern healthcare facilities 1, 4
  • The case-fatality ratio is highest in infants and the elderly 1, 4
  • Long-term neurologic sequelae and intellectual and behavioral abnormalities may follow recovery 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intensive Care Management of Severe Tetanus.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2021

Research

Tetanus: a review.

Critical care medicine, 1979

Guideline

Tetanus Clinical Presentation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Current concepts in the management of Clostridium tetani infection.

Expert review of anti-infective therapy, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.